JP2020164486A - 抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料 - Google Patents

抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料 Download PDF

Info

Publication number: JP2020164486A
Authority: JP; Japan
Prior art keywords: fermented; production example; aspergillus; test sample; particularly limited
Prior art date: 2019-03-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP2019068953A

Other languages

English (en)

Japanese (ja)

Inventor

美和岩竹

Miwa Iwatake

美和岩竹

浩誠桑原

Hiromoto Kuwabara

浩誠桑原

信明大戸

Nobuaki Oto

信明大戸

高士染谷

Takashi Someya

高士染谷

薫萩谷

Kaoru Hagitani

薫萩谷

弘子川野辺

Hiroko Kawanobe

弘子川野辺

佐藤　勉

Tsutomu Sato

勉佐藤

昭仁高橋

Akihito Takahashi

昭仁高橋

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Maruzen Pharmaceutical Co Ltd

Akita Prefectural University

Albion Co Ltd

Original Assignee

Maruzen Pharmaceutical Co Ltd

Akita Prefectural University

Albion Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2019-03-29

Filing date

2019-03-29

Publication date

2020-10-08

2019-03-29 Application filed by Maruzen Pharmaceutical Co Ltd, Akita Prefectural University, Albion Co Ltd filed Critical Maruzen Pharmaceutical Co Ltd

2019-03-29 Priority to JP2019068953A priority Critical patent/JP2020164486A/ja

2020-03-27 Priority to PCT/JP2020/014395 priority patent/WO2020203933A1/ja

2020-03-27 Priority to KR1020217030978A priority patent/KR20210144725A/ko

2020-03-27 Priority to CN202080024053.0A priority patent/CN113631227B/zh

2020-03-30 Priority to TW109110866A priority patent/TW202102239A/zh

2020-03-30 Priority to TW113106233A priority patent/TWI857919B/zh

2020-10-08 Publication of JP2020164486A publication Critical patent/JP2020164486A/ja

2023-10-05 Priority to JP2023173573A priority patent/JP2023171950A/ja

Status Pending legal-status Critical Current

Links

239000003795 chemical substances by application Substances 0.000 title claims abstract description 76
230000003712 anti-aging effect Effects 0.000 title claims abstract description 69
239000003963 antioxidant agent Substances 0.000 title claims abstract description 40
239000002260 anti-inflammatory agent Substances 0.000 title claims abstract description 37
229940121363 anti-inflammatory agent Drugs 0.000 title claims abstract description 37
239000002537 cosmetic Substances 0.000 title claims abstract description 30
239000007844 bleaching agent Substances 0.000 title description 5
230000003078 antioxidant effect Effects 0.000 claims abstract description 67
230000002087 whitening effect Effects 0.000 claims abstract description 64
239000004480 active ingredient Substances 0.000 claims abstract description 23
241000196324 Embryophyta Species 0.000 claims description 73
244000062730 Melissa officinalis Species 0.000 claims description 44
235000010654 Melissa officinalis Nutrition 0.000 claims description 43
240000006439 Aspergillus oryzae Species 0.000 claims description 34
235000002247 Aspergillus oryzae Nutrition 0.000 claims description 34
239000007788 liquid Substances 0.000 abstract description 193
238000000855 fermentation Methods 0.000 abstract description 113
230000004151 fermentation Effects 0.000 abstract description 112
230000003110 anti-inflammatory effect Effects 0.000 abstract description 24
230000009471 action Effects 0.000 abstract description 20
244000065027 Artemisia princeps Species 0.000 abstract description 14
235000017519 Artemisia princeps Nutrition 0.000 abstract description 13
238000010586 diagram Methods 0.000 abstract 1
238000012360 testing method Methods 0.000 description 284
238000004519 manufacturing process Methods 0.000 description 195
239000000523 sample Substances 0.000 description 124
241000228212 Aspergillus Species 0.000 description 120
240000004385 Centaurea cyanus Species 0.000 description 115
235000005940 Centaurea cyanus Nutrition 0.000 description 114
108020004999 messenger RNA Proteins 0.000 description 103
238000000034 method Methods 0.000 description 82
240000006891 Artemisia vulgaris Species 0.000 description 74
230000001737 promoting effect Effects 0.000 description 72
210000004027 cell Anatomy 0.000 description 70
239000000284 extract Substances 0.000 description 68
239000002609 medium Substances 0.000 description 62
239000000243 solution Substances 0.000 description 60
230000000052 comparative effect Effects 0.000 description 56
239000002994 raw material Substances 0.000 description 55
210000003491 skin Anatomy 0.000 description 55
235000003261 Artemisia vulgaris Nutrition 0.000 description 50
230000000694 effects Effects 0.000 description 49
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 49
210000005175 epidermal keratinocyte Anatomy 0.000 description 46
108091032973 (ribonucleotides)n+m Proteins 0.000 description 35
235000006708 antioxidants Nutrition 0.000 description 35
240000002657 Thymus vulgaris Species 0.000 description 34
235000007303 Thymus vulgaris Nutrition 0.000 description 34
239000000047 product Substances 0.000 description 33
238000002835 absorbance Methods 0.000 description 31
235000003097 Artemisia absinthium Nutrition 0.000 description 30
238000002360 preparation method Methods 0.000 description 30
235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 29
235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 29
239000001138 artemisia absinthium Substances 0.000 description 29
230000002401 inhibitory effect Effects 0.000 description 29
KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 29
102000004363 Aquaporin 3 Human genes 0.000 description 26
108090000991 Aquaporin 3 Proteins 0.000 description 26
239000001585 thymus vulgaris Substances 0.000 description 23
239000007640 basal medium Substances 0.000 description 21
238000010438 heat treatment Methods 0.000 description 20
102100030944 Protein-glutamine gamma-glutamyltransferase K Human genes 0.000 description 19
108010058734 transglutaminase 1 Proteins 0.000 description 19
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
230000007423 decrease Effects 0.000 description 17
108010003272 Hyaluronate lyase Proteins 0.000 description 16
102000001974 Hyaluronidases Human genes 0.000 description 16
102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 16
108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 16
102000003940 Occludin Human genes 0.000 description 16
108090000304 Occludin Proteins 0.000 description 16
229960002773 hyaluronidase Drugs 0.000 description 16
102000012422 Collagen Type I Human genes 0.000 description 15
108010022452 Collagen Type I Proteins 0.000 description 15
238000011481 absorbance measurement Methods 0.000 description 15
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 15
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 15
235000003826 Artemisia Nutrition 0.000 description 14
101710197055 Hyaluronan synthase 3 Proteins 0.000 description 14
102100029425 Hyaluronan synthase 3 Human genes 0.000 description 14
102000003425 Tyrosinase Human genes 0.000 description 14
108060008724 Tyrosinase Proteins 0.000 description 14
235000009052 artemisia Nutrition 0.000 description 14
230000037319 collagen production Effects 0.000 description 14
238000012937 correction Methods 0.000 description 14
238000001035 drying Methods 0.000 description 14
239000000126 substance Substances 0.000 description 14
102100028314 Filaggrin Human genes 0.000 description 13
101710088660 Filaggrin Proteins 0.000 description 13
238000003753 real-time PCR Methods 0.000 description 13
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 12
230000002292 Radical scavenging effect Effects 0.000 description 12
239000007787 solid Substances 0.000 description 12
238000010998 test method Methods 0.000 description 12
102000004190 Enzymes Human genes 0.000 description 11
108090000790 Enzymes Proteins 0.000 description 11
MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 11
229940088598 enzyme Drugs 0.000 description 11
239000012091 fetal bovine serum Substances 0.000 description 11
239000012488 sample solution Substances 0.000 description 11
102000004162 Claudin-1 Human genes 0.000 description 10
108090000600 Claudin-1 Proteins 0.000 description 10
102000004161 Claudin-4 Human genes 0.000 description 10
108090000601 Claudin-4 Proteins 0.000 description 10
239000001522 artemisia absinthium l. herb extract Substances 0.000 description 10
-1 lipid peroxide Chemical class 0.000 description 10
230000008099 melanin synthesis Effects 0.000 description 10
229940119569 wormwood extract Drugs 0.000 description 10
240000007594 Oryza sativa Species 0.000 description 9
235000007164 Oryza sativa Nutrition 0.000 description 9
102000004142 Trypsin Human genes 0.000 description 9
108090000631 Trypsin Proteins 0.000 description 9
239000003153 chemical reaction reagent Substances 0.000 description 9
238000012258 culturing Methods 0.000 description 9
238000011081 inoculation Methods 0.000 description 9
239000000865 liniment Substances 0.000 description 9
238000005259 measurement Methods 0.000 description 9
235000009566 rice Nutrition 0.000 description 9
239000012588 trypsin Substances 0.000 description 9
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 8
OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 8
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
230000004888 barrier function Effects 0.000 description 8
230000015572 biosynthetic process Effects 0.000 description 8
239000000872 buffer Substances 0.000 description 8
238000006243 chemical reaction Methods 0.000 description 8
239000012141 concentrate Substances 0.000 description 8
235000008504 concentrate Nutrition 0.000 description 8
238000001914 filtration Methods 0.000 description 8
239000004615 ingredient Substances 0.000 description 8
239000006210 lotion Substances 0.000 description 8
239000001301 oxygen Substances 0.000 description 8
229910052760 oxygen Inorganic materials 0.000 description 8
238000003757 reverse transcription PCR Methods 0.000 description 8
239000002904 solvent Substances 0.000 description 8
102000040650 (ribonucleotides)n+m Human genes 0.000 description 7
102000008186 Collagen Human genes 0.000 description 7
108010035532 Collagen Proteins 0.000 description 7
206010016807 Fluid retention Diseases 0.000 description 7
NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 7
238000002123 RNA extraction Methods 0.000 description 7
230000032683 aging Effects 0.000 description 7
229920001436 collagen Polymers 0.000 description 7
238000001514 detection method Methods 0.000 description 7
239000001963 growth medium Substances 0.000 description 7
229920002674 hyaluronan Polymers 0.000 description 7
230000005764 inhibitory process Effects 0.000 description 7
210000002510 keratinocyte Anatomy 0.000 description 7
229930014626 natural product Natural products 0.000 description 7
230000035755 proliferation Effects 0.000 description 7
239000012264 purified product Substances 0.000 description 7
239000008213 purified water Substances 0.000 description 7
210000000434 stratum corneum Anatomy 0.000 description 7
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 6
241000132570 Centaurea Species 0.000 description 6
102000002029 Claudin Human genes 0.000 description 6
108050009302 Claudin Proteins 0.000 description 6
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
102000003918 Hyaluronan Synthases Human genes 0.000 description 6
108090000320 Hyaluronan Synthases Proteins 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
238000001816 cooling Methods 0.000 description 6
239000006071 cream Substances 0.000 description 6
210000002615 epidermis Anatomy 0.000 description 6
230000006870 function Effects 0.000 description 6
229960003160 hyaluronic acid Drugs 0.000 description 6
239000000843 powder Substances 0.000 description 6
208000024891 symptom Diseases 0.000 description 6
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 6
LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 5
YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 5
DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 5
208000001382 Experimental Melanoma Diseases 0.000 description 5
241000282412 Homo Species 0.000 description 5
AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 5
235000010633 broth Nutrition 0.000 description 5
235000013399 edible fruits Nutrition 0.000 description 5
239000003205 fragrance Substances 0.000 description 5
239000000203 mixture Substances 0.000 description 5
239000002453 shampoo Substances 0.000 description 5
230000009759 skin aging Effects 0.000 description 5
210000001519 tissue Anatomy 0.000 description 5
230000037303 wrinkles Effects 0.000 description 5
229920001817 Agar Polymers 0.000 description 4
235000015701 Artemisia arbuscula Nutrition 0.000 description 4
241000092668 Artemisia capillaris Species 0.000 description 4
235000008658 Artemisia capillaris Nutrition 0.000 description 4
235000002657 Artemisia tridentata Nutrition 0.000 description 4
241000208838 Asteraceae Species 0.000 description 4
241000894006 Bacteria Species 0.000 description 4
238000002965 ELISA Methods 0.000 description 4
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 4
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 4
QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
241000207923 Lamiaceae Species 0.000 description 4
235000010724 Wisteria floribunda Nutrition 0.000 description 4
239000008272 agar Substances 0.000 description 4
238000007865 diluting Methods 0.000 description 4
238000010790 dilution Methods 0.000 description 4
239000012895 dilution Substances 0.000 description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
210000002744 extracellular matrix Anatomy 0.000 description 4
238000004108 freeze drying Methods 0.000 description 4
230000035784 germination Effects 0.000 description 4
239000008233 hard water Substances 0.000 description 4
239000000463 material Substances 0.000 description 4
230000003020 moisturizing effect Effects 0.000 description 4
239000002304 perfume Substances 0.000 description 4
108090000623 proteins and genes Proteins 0.000 description 4
230000001954 sterilising effect Effects 0.000 description 4
HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 3
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
102000010637 Aquaporins Human genes 0.000 description 3
240000002877 Artemisia absinthium Species 0.000 description 3
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
241001354404 Cyanus Species 0.000 description 3
206010013786 Dry skin Diseases 0.000 description 3
206010014970 Ephelides Diseases 0.000 description 3
108700041153 Filaggrin Proteins Proteins 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
108010076876 Keratins Proteins 0.000 description 3
102000011782 Keratins Human genes 0.000 description 3
102000002274 Matrix Metalloproteinases Human genes 0.000 description 3
108010000684 Matrix Metalloproteinases Proteins 0.000 description 3
208000003351 Melanosis Diseases 0.000 description 3
235000012629 Mentha aquatica Nutrition 0.000 description 3
244000173610 Mentha aquatica Species 0.000 description 3
229910019142 PO4 Inorganic materials 0.000 description 3
208000012641 Pigmentation disease Diseases 0.000 description 3
229920001213 Polysorbate 20 Polymers 0.000 description 3
102000019197 Superoxide Dismutase Human genes 0.000 description 3
108010012715 Superoxide dismutase Proteins 0.000 description 3
230000002159 abnormal effect Effects 0.000 description 3
239000008351 acetate buffer Substances 0.000 description 3
150000001413 amino acids Chemical class 0.000 description 3
239000003212 astringent agent Substances 0.000 description 3
230000003796 beauty Effects 0.000 description 3
239000001110 calcium chloride Substances 0.000 description 3
229910001628 calcium chloride Inorganic materials 0.000 description 3
230000003833 cell viability Effects 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
201000010099 disease Diseases 0.000 description 3
230000037336 dry skin Effects 0.000 description 3
230000001747 exhibiting effect Effects 0.000 description 3
235000013305 food Nutrition 0.000 description 3
239000008187 granular material Substances 0.000 description 3
235000015110 jellies Nutrition 0.000 description 3
230000007246 mechanism Effects 0.000 description 3
239000002674 ointment Substances 0.000 description 3
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
239000010452 phosphate Substances 0.000 description 3
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
230000008569 process Effects 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
239000000344 soap Substances 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
229960000278 theophylline Drugs 0.000 description 3
108010063290 Aquaporins Proteins 0.000 description 2
206010003210 Arteriosclerosis Diseases 0.000 description 2
241000131386 Aspergillus sojae Species 0.000 description 2
235000010082 Averrhoa carambola Nutrition 0.000 description 2
240000006063 Averrhoa carambola Species 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
241000282472 Canis lupus familiaris Species 0.000 description 2
208000002177 Cataract Diseases 0.000 description 2
241000282693 Cercopithecidae Species 0.000 description 2
241000207199 Citrus Species 0.000 description 2
241000220284 Crassulaceae Species 0.000 description 2
241000699800 Cricetinae Species 0.000 description 2
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
241000282326 Felis catus Species 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
239000005909 Kieselgur Substances 0.000 description 2
WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
235000006679 Mentha X verticillata Nutrition 0.000 description 2
244000246386 Mentha pulegium Species 0.000 description 2
235000016257 Mentha pulegium Nutrition 0.000 description 2
235000002899 Mentha suaveolens Nutrition 0.000 description 2
235000004357 Mentha x piperita Nutrition 0.000 description 2
235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 2
241000700159 Rattus Species 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
208000006011 Stroke Diseases 0.000 description 2
241000282887 Suidae Species 0.000 description 2
244000269722 Thea sinensis Species 0.000 description 2
208000026062 Tissue disease Diseases 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
241000219995 Wisteria Species 0.000 description 2
239000012190 activator Substances 0.000 description 2
239000000853 adhesive Substances 0.000 description 2
230000001070 adhesive effect Effects 0.000 description 2
150000001298 alcohols Chemical class 0.000 description 2
230000001668 ameliorated effect Effects 0.000 description 2
208000011775 arteriosclerosis disease Diseases 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
238000003287 bathing Methods 0.000 description 2
238000011088 calibration curve Methods 0.000 description 2
235000020971 citrus fruits Nutrition 0.000 description 2
239000003086 colorant Substances 0.000 description 2
239000000470 constituent Substances 0.000 description 2
230000006378 damage Effects 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
210000004207 dermis Anatomy 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
230000004069 differentiation Effects 0.000 description 2
239000002552 dosage form Substances 0.000 description 2
210000001339 epidermal cell Anatomy 0.000 description 2
238000000605 extraction Methods 0.000 description 2
210000002950 fibroblast Anatomy 0.000 description 2
235000001050 hortel pimenta Nutrition 0.000 description 2
230000001771 impaired effect Effects 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
230000003780 keratinization Effects 0.000 description 2
108010075526 keratohyalin Proteins 0.000 description 2
239000002932 luster Substances 0.000 description 2
238000002156 mixing Methods 0.000 description 2
208000010125 myocardial infarction Diseases 0.000 description 2
PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 2
239000000825 pharmaceutical preparation Substances 0.000 description 2
229940127557 pharmaceutical product Drugs 0.000 description 2
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
230000009467 reduction Effects 0.000 description 2
206010039073 rheumatoid arthritis Diseases 0.000 description 2
239000013049 sediment Substances 0.000 description 2
230000008591 skin barrier function Effects 0.000 description 2
210000000498 stratum granulosum Anatomy 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
239000002562 thickening agent Substances 0.000 description 2
235000015961 tonic Nutrition 0.000 description 2
230000001256 tonic effect Effects 0.000 description 2
229960000716 tonics Drugs 0.000 description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
238000005406 washing Methods 0.000 description 2
OCZVHBZNPVABKX-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine;ethanol Chemical compound CCO.[O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 OCZVHBZNPVABKX-UHFFFAOYSA-N 0.000 description 1
OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
WTFUTSCZYYCBAY-SXBRIOAWSA-N 6-[(E)-C-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-N-hydroxycarbonimidoyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C/C(=N/O)/C1=CC2=C(NC(O2)=O)C=C1 WTFUTSCZYYCBAY-SXBRIOAWSA-N 0.000 description 1
DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
LLQHSBBZNDXTIV-UHFFFAOYSA-N 6-[5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC1CC(=NO1)C1=CC2=C(NC(O2)=O)C=C1 LLQHSBBZNDXTIV-UHFFFAOYSA-N 0.000 description 1
102100023987 Aquaporin-12A Human genes 0.000 description 1
241000271889 Artemisia japonica Species 0.000 description 1
235000017521 Artemisia japonica Nutrition 0.000 description 1
240000004950 Artemisia lactiflora Species 0.000 description 1
235000004355 Artemisia lactiflora Nutrition 0.000 description 1
235000003107 Artemisia maritima Nutrition 0.000 description 1
240000008118 Artemisia maritima Species 0.000 description 1
241000638253 Artemisia montana Species 0.000 description 1
235000004356 Artemisia montana Nutrition 0.000 description 1
241001249148 Artemisia scoparia Species 0.000 description 1
235000003069 Artemisia scoparia Nutrition 0.000 description 1
241000459887 Aspergillus luchuensis Species 0.000 description 1
241000167854 Bourreria succulenta Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
241000193403 Clostridium Species 0.000 description 1
102000029816 Collagenase Human genes 0.000 description 1
108060005980 Collagenase Proteins 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
241000037740 Coptis chinensis Species 0.000 description 1
201000004624 Dermatitis Diseases 0.000 description 1
206010012438 Dermatitis atopic Diseases 0.000 description 1
206010012442 Dermatitis contact Diseases 0.000 description 1
AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
239000004278 EU approved seasoning Substances 0.000 description 1
102000016942 Elastin Human genes 0.000 description 1
108010014258 Elastin Proteins 0.000 description 1
241000237537 Ensis Species 0.000 description 1
208000010201 Exanthema Diseases 0.000 description 1
206010064503 Excessive skin Diseases 0.000 description 1
241000187795 Ficus umbellata Species 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
101000757607 Homo sapiens Aquaporin-12A Proteins 0.000 description 1
102000004157 Hydrolases Human genes 0.000 description 1
108090000604 Hydrolases Proteins 0.000 description 1
AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
102100023487 Lens fiber major intrinsic protein Human genes 0.000 description 1
DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
229930184510 Mallotus Natural products 0.000 description 1
241001060384 Mallotus <angiosperm> Species 0.000 description 1
239000004909 Moisturizer Substances 0.000 description 1
241000218231 Moraceae Species 0.000 description 1
NEAPKZHDYMQZCB-UHFFFAOYSA-N N-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]ethyl]-2-oxo-3H-1,3-benzoxazole-6-carboxamide Chemical compound C1CN(CCN1CCNC(=O)C2=CC3=C(C=C2)NC(=O)O3)C4=CN=C(N=C4)NC5CC6=CC=CC=C6C5 NEAPKZHDYMQZCB-UHFFFAOYSA-N 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
229940123973 Oxygen scavenger Drugs 0.000 description 1
201000011152 Pemphigus Diseases 0.000 description 1
240000000275 Persicaria hydropiper Species 0.000 description 1
235000017337 Persicaria hydropiper Nutrition 0.000 description 1
241000218657 Picea Species 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
240000000528 Ricinus communis Species 0.000 description 1
235000004443 Ricinus communis Nutrition 0.000 description 1
ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
241000133134 Saussurea Species 0.000 description 1
206010040880 Skin irritation Diseases 0.000 description 1
206010040954 Skin wrinkling Diseases 0.000 description 1
229920002385 Sodium hyaluronate Polymers 0.000 description 1
241000700605 Viruses Species 0.000 description 1
241000234299 Zingiberaceae Species 0.000 description 1
239000006096 absorbing agent Substances 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
230000003679 aging effect Effects 0.000 description 1
230000007815 allergy Effects 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
108010018755 aquaporin 0 Proteins 0.000 description 1
201000008937 atopic dermatitis Diseases 0.000 description 1
239000003899 bactericide agent Substances 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
239000004327 boric acid Substances 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
239000002775 capsule Substances 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
235000019693 cherries Nutrition 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
229940096422 collagen type i Drugs 0.000 description 1
229960002424 collagenase Drugs 0.000 description 1
238000010276 construction Methods 0.000 description 1
208000010247 contact dermatitis Diseases 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
210000004292 cytoskeleton Anatomy 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
230000030609 dephosphorylation Effects 0.000 description 1
238000006209 dephosphorylation reaction Methods 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
229910001882 dioxygen Inorganic materials 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
239000003814 drug Substances 0.000 description 1
229920002549 elastin Polymers 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000037149 energy metabolism Effects 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
239000000686 essence Substances 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
201000005884 exanthem Diseases 0.000 description 1
210000001723 extracellular space Anatomy 0.000 description 1
239000003925 fat Substances 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
229930003949 flavanone Natural products 0.000 description 1
235000011981 flavanones Nutrition 0.000 description 1
235000011194 food seasoning agent Nutrition 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
235000011389 fruit/vegetable juice Nutrition 0.000 description 1
229930182470 glycoside Natural products 0.000 description 1
239000003676 hair preparation Substances 0.000 description 1
210000003630 histaminocyte Anatomy 0.000 description 1
230000013632 homeostatic process Effects 0.000 description 1
KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
229940099552 hyaluronan Drugs 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
230000006872 improvement Effects 0.000 description 1
208000027866 inflammatory disease Diseases 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
239000000543 intermediate Substances 0.000 description 1
102000007236 involucrin Human genes 0.000 description 1
108010033564 involucrin Proteins 0.000 description 1
239000008274 jelly Substances 0.000 description 1
239000007934 lip balm Substances 0.000 description 1
DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
229940126601 medicinal product Drugs 0.000 description 1
239000012528 membrane Substances 0.000 description 1
229940105902 mint extract Drugs 0.000 description 1
230000001333 moisturizer Effects 0.000 description 1
235000020729 noni extract Nutrition 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000014593 oils and fats Nutrition 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
230000001151 other effect Effects 0.000 description 1
238000012261 overproduction Methods 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
201000001976 pemphigus vulgaris Diseases 0.000 description 1
229940116257 pepper extract Drugs 0.000 description 1
210000001539 phagocyte Anatomy 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
239000008055 phosphate buffer solution Substances 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
210000004694 pigment cell Anatomy 0.000 description 1
230000019612 pigmentation Effects 0.000 description 1
239000000419 plant extract Substances 0.000 description 1
229910052697 platinum Inorganic materials 0.000 description 1
238000003825 pressing Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000009993 protective function Effects 0.000 description 1
239000002516 radical scavenger Substances 0.000 description 1
206010037844 rash Diseases 0.000 description 1
238000011160 research Methods 0.000 description 1
229940109850 royal jelly Drugs 0.000 description 1
210000004761 scalp Anatomy 0.000 description 1
238000007789 sealing Methods 0.000 description 1
210000004927 skin cell Anatomy 0.000 description 1
208000017520 skin disease Diseases 0.000 description 1
230000036556 skin irritation Effects 0.000 description 1
231100000475 skin irritation Toxicity 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
229940010747 sodium hyaluronate Drugs 0.000 description 1
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
239000007858 starting material Substances 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
239000000829 suppository Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000003826 tablet Substances 0.000 description 1
210000001550 testis Anatomy 0.000 description 1
210000001541 thymus gland Anatomy 0.000 description 1
210000001578 tight junction Anatomy 0.000 description 1
230000014616 translation Effects 0.000 description 1
239000006097 ultraviolet radiation absorber Substances 0.000 description 1
230000008728 vascular permeability Effects 0.000 description 1
239000001993 wax Substances 0.000 description 1
238000009736 wetting Methods 0.000 description 1
230000037373 wrinkle formation Effects 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Natural Medicines & Medicinal Plants (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Mycology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Biotechnology (AREA)
Botany (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medical Informatics (AREA)
Alternative & Traditional Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Birds (AREA)
Gerontology & Geriatric Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Medicines Containing Plant Substances (AREA)
Cosmetics (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

JP2019068953A 2019-03-29 2019-03-29 抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料 Pending JP2020164486A (ja)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
JP2019068953A JP2020164486A (ja)	2019-03-29	2019-03-29	抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料
PCT/JP2020/014395 WO2020203933A1 (ja)	2019-03-29	2020-03-27	抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料
KR1020217030978A KR20210144725A (ko)	2019-03-29	2020-03-27	항노화제, 항산화제, 항염증제 및 미백제, 그리고 화장료
CN202080024053.0A CN113631227B (zh)	2019-03-29	2020-03-27	抗老化剂、抗氧化剂、抗炎剂、及美白剂、以及化妆品
TW109110866A TW202102239A (zh)	2019-03-29	2020-03-30	抗老化劑、抗氧化劑、抗炎症劑、及美白劑、以及化妝品
TW113106233A TWI857919B (zh)	2019-03-29	2020-03-30	抗炎症劑以及化妝品
JP2023173573A JP2023171950A (ja)	2019-03-29	2023-10-05	抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2019068953A JP2020164486A (ja)	2019-03-29	2019-03-29	抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2023173573A Division JP2023171950A (ja)	2019-03-29	2023-10-05	抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料

Publications (1)

Publication Number	Publication Date
JP2020164486A true JP2020164486A (ja)	2020-10-08

Family

ID=72669004

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
JP2019068953A Pending JP2020164486A (ja)	2019-03-29	2019-03-29	抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料
JP2023173573A Pending JP2023171950A (ja)	2019-03-29	2023-10-05	抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
JP2023173573A Pending JP2023171950A (ja)	2019-03-29	2023-10-05	抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料

Country Status (5)

Country	Link
JP (2)	JP2020164486A (zh)
KR (1)	KR20210144725A (zh)
CN (1)	CN113631227B (zh)
TW (2)	TWI857919B (zh)
WO (1)	WO2020203933A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP7613935B2 (ja)	2021-02-11	2025-01-15	月桂冠株式会社	フィラグリン増量剤

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN113230175B (zh) *	2021-05-28	2023-02-03	潍坊职业学院	一种含有梧桐提取物的化妆品以及梧桐提取物的提取方法
CN118217205B (zh) *	2024-04-01	2025-01-24	广东科誉新材料有限公司	一种增强头发光泽的洗发香波

Citations (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS60104005A (ja) *	1983-11-08	1985-06-08	Kobayashi Kooc:Kk	美白化粧料
JPH06199647A (ja) *	1992-12-28	1994-07-19	Noevir Co Ltd	美白化粧料
JPH0930953A (ja) *	1995-07-21	1997-02-04	Noevir Co Ltd	皮膚外用剤
JP2003061612A (ja) *	2001-08-29	2003-03-04	Amano:Kk	健康食品用発酵液及びその製造方法。
JP2004075645A (ja) *	2002-08-22	2004-03-11	Kanebo Ltd	化粧料
JP2009511468A (ja) *	2005-10-05	2009-03-19	アンジオラブインコーポレーテッド	抗肥満組成物
WO2009113446A1 (ja) *	2008-03-11	2009-09-17	株式会社資生堂	皮膚美白方法、並びに、皮膚シミ形成抑制及び／又は除去因子のスクリーニング方法
JP2009242263A (ja) *	2008-03-28	2009-10-22	Maruzen Pharmaceut Co Ltd	抗老化剤、並びに、皮膚外用剤及び飲食品
JP2010043088A (ja) *	2004-03-15	2010-02-25	Kyoei Kagaku Kogyo Kk	化粧料
JP2011162457A (ja) *	2010-02-05	2011-08-25	Maruzen Pharmaceut Co Ltd	植物発酵エキス及びその製造方法、並びに化粧料
KR20110114801A (ko) *	2010-04-14	2011-10-20	노옥희	메주,누룩을 주원료로 하고 곡류. 한약재, 과실류, 버섯류, 야채류, 수산물류를 부원료로 하여 특정 발효조를 이용한 발효효모의 제조방법
JP2011231030A (ja) *	2010-04-26	2011-11-17	Toyo Shinyaku Co Ltd	美白剤
JP2012092100A (ja) *	2010-10-25	2012-05-17	Amorepacific Corp	緑茶抽出物を含有する美白用化粧料組成物
US20130071376A1 (en) *	2009-12-30	2013-03-21	Dong-Joo Lee	Bathing composition and method for preparing same

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2001213757A (ja)	2000-01-28	2001-08-07	Maruzen Pharmaceut Co Ltd	メラニン産生抑制剤および美白用化粧料
JP2001261568A (ja)	2000-03-16	2001-09-26	Kanebo Ltd	プロフィラグリン及び／又はフィラグリン蛋白産生促進剤
JP3658548B2 (ja)	2000-10-24	2005-06-08	丸善製薬株式会社	美白化粧料
JP4658348B2 (ja)	2001-02-02	2011-03-23	丸善製薬株式会社	コラーゲン産生促進剤、コラゲナーゼ阻害剤、線維芽細胞増殖作用剤、エラスターゼ阻害剤、エストロゲン様作用剤、並びに皮膚化粧料
JP4813690B2 (ja)	2001-06-05	2011-11-09	丸善製薬株式会社	フィラグリン合成促進剤、角質層保湿機能改善・増強剤および角質層遊離アミノ酸量増加剤
JP2002370962A (ja)	2001-06-13	2002-12-24	Maruzen Pharmaceut Co Ltd	美白用化粧料および皮膚老化防止・改善用化粧料
JP5060690B2 (ja)	2001-07-06	2012-10-31	丸善製薬株式会社	サイクリックａｍｐホスホジエステラーゼ阻害剤
JP5058414B2 (ja)	2001-08-06	2012-10-24	丸善製薬株式会社	皮膚化粧料並びに飲食品
JP5095893B2 (ja)	2001-09-13	2012-12-12	丸善製薬株式会社	活性酸素消去剤
JP3709369B2 (ja)	2001-11-13	2005-10-26	丸善製薬株式会社	皮膚化粧料及び美容用飲食品
JP2003146886A (ja)	2001-11-14	2003-05-21	Noevir Co Ltd	フィラグリン合成促進剤、及び角質層保湿機能改善剤，角質層柔軟化剤，角質層遊離アミノ酸増加剤
JP2003176232A (ja)	2001-12-12	2003-06-24	Maruzen Pharmaceut Co Ltd	皮膚外用剤及び飲食品
JP4202638B2 (ja)	2001-12-12	2008-12-24	丸善製薬株式会社	コラーゲン産生促進剤、エラスターゼ阻害剤、コラゲナーゼ阻害剤及び老化防止用皮膚化粧料
JP4610845B2 (ja)	2002-08-27	2011-01-12	丸善製薬株式会社	美白用化粧料及び美白用飲食品
JP2005029483A (ja)	2003-07-09	2005-02-03	Maruzen Pharmaceut Co Ltd	活性酸素消去剤、並びに化粧料及び飲食物
JP2006321730A (ja)	2005-05-17	2006-11-30	Maruzen Pharmaceut Co Ltd	抗酸化剤及び抗老化剤、並びに皮膚化粧料及び飲食物
JP4722595B2 (ja)	2005-07-04	2011-07-13	丸善製薬株式会社	抗炎症剤、抗酸化剤及び美白剤、並びに皮膚化粧料
JP2007176835A (ja)	2005-12-27	2007-07-12	Pola Chem Ind Inc	皮膚バリア機能を向上させるための皮膚外用剤とその製造法
JP2007176830A (ja)	2005-12-27	2007-07-12	Pola Chem Ind Inc	皮膚バリア機能を向上させるための皮膚外用剤とその製造法
WO2007143851A1 (en) *	2006-06-16	2007-12-21	Kefiplant Inc.	Fermented plant extracts, methods of production and uses
JP5235439B2 (ja)	2008-02-06	2013-07-10	丸善製薬株式会社	ＨＭＧ−ＣｏＡ還元酵素産生促進剤
JP2009191039A (ja)	2008-02-15	2009-08-27	Maruzen Pharmaceut Co Ltd	ヒアルロン酸合成酵素３ｍＲＮＡ発現促進剤、アクアポリン３ｍＲＮＡ発現促進剤、セリンパルミトイルトランスフェラーゼｍＲＮＡ発現促進剤及びラミニン５産生促進剤
KR20090103823A (ko) *	2008-03-28	2009-10-01	마루젠세이야쿠 가부시키가이샤	항노화제, 피부외용제 및 음식품
JP5860579B2 (ja)	2008-10-10	2016-02-16	丸善製薬株式会社	フィラグリン産生促進剤、インボルクリン産生促進剤、及びトランスグルタミナーゼ−１産生促進剤
JP2011130689A (ja)	2009-12-24	2011-07-07	Kirin Kyowa Foods Co Ltd	抗酸化能を有する調味液、その製造方法、および当該調味液を含む飲食品
JP2011140453A (ja) *	2010-01-06	2011-07-21	Tadatoshi Karatsu	発酵薬草乾燥物の製造方法および発酵薬草粉末
CN102985064B (zh) *	2010-06-11	2014-11-05	李东柱	沐浴组合物及其制备方法
KR101167295B1 (ko) *	2011-02-22	2012-07-23	주식회사 사임당화장품	한방발효복합추출물을 유효성분으로 함유하는 인체 피부 노화 방지용 화장료 조성물 및 그 제조방법
KR20130085012A (ko) *	2012-01-18	2013-07-26	주식회사 엘지생활건강	발효물을 포함하는 화장료 조성물 및 이의 제조방법
KR20140109221A (ko) *	2013-03-05	2014-09-15	호서대학교 산학협력단	산쑥 에센셜 오일을 유효성분으로 함유하는 피부 재생용 화장료 및 피부 외용제 조성물
KR101835739B1 (ko) *	2014-06-30	2018-03-08	주식회사 에스엘바이젠	인진쑥 추출물 또는 이의 분획물을 유효성분으로 함유하는 조성물
JP6433053B2 (ja) *	2014-09-10	2018-12-05	オリザ油化株式会社	皮脂腺細胞における脂質蓄積促進剤
KR101532003B1 (ko) *	2014-10-29	2015-06-26	재단법인 금산국제인삼약초연구소	발효 조성물을 함유하는 피부 항산화 기능성 화장품
CN108968018A (zh) *	2018-06-25	2018-12-11	贵州古香园酿造调味品有限公司	一种甜面酱及其制备方法
CN109370835A (zh) *	2018-12-24	2019-02-22	湖北襄醉酒业有限公司	一种营养型南瓜白兰地酒及其制备方法

2019
- 2019-03-29 JP JP2019068953A patent/JP2020164486A/ja active Pending
2020
- 2020-03-27 KR KR1020217030978A patent/KR20210144725A/ko not_active Ceased
- 2020-03-27 WO PCT/JP2020/014395 patent/WO2020203933A1/ja active Application Filing
- 2020-03-27 CN CN202080024053.0A patent/CN113631227B/zh active Active
- 2020-03-30 TW TW113106233A patent/TWI857919B/zh active
- 2020-03-30 TW TW109110866A patent/TW202102239A/zh unknown
2023
- 2023-10-05 JP JP2023173573A patent/JP2023171950A/ja active Pending

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS60104005A (ja) *	1983-11-08	1985-06-08	Kobayashi Kooc:Kk	美白化粧料
JPH06199647A (ja) *	1992-12-28	1994-07-19	Noevir Co Ltd	美白化粧料
JPH0930953A (ja) *	1995-07-21	1997-02-04	Noevir Co Ltd	皮膚外用剤
JP2003061612A (ja) *	2001-08-29	2003-03-04	Amano:Kk	健康食品用発酵液及びその製造方法。
JP2004075645A (ja) *	2002-08-22	2004-03-11	Kanebo Ltd	化粧料
JP2010043088A (ja) *	2004-03-15	2010-02-25	Kyoei Kagaku Kogyo Kk	化粧料
JP2009511468A (ja) *	2005-10-05	2009-03-19	アンジオラブインコーポレーテッド	抗肥満組成物
WO2009113446A1 (ja) *	2008-03-11	2009-09-17	株式会社資生堂	皮膚美白方法、並びに、皮膚シミ形成抑制及び／又は除去因子のスクリーニング方法
JP2009242263A (ja) *	2008-03-28	2009-10-22	Maruzen Pharmaceut Co Ltd	抗老化剤、並びに、皮膚外用剤及び飲食品
US20130071376A1 (en) *	2009-12-30	2013-03-21	Dong-Joo Lee	Bathing composition and method for preparing same
JP2011162457A (ja) *	2010-02-05	2011-08-25	Maruzen Pharmaceut Co Ltd	植物発酵エキス及びその製造方法、並びに化粧料
KR20110114801A (ko) *	2010-04-14	2011-10-20	노옥희	메주,누룩을 주원료로 하고 곡류. 한약재, 과실류, 버섯류, 야채류, 수산물류를 부원료로 하여 특정 발효조를 이용한 발효효모의 제조방법
JP2011231030A (ja) *	2010-04-26	2011-11-17	Toyo Shinyaku Co Ltd	美白剤
JP2012092100A (ja) *	2010-10-25	2012-05-17	Amorepacific Corp	緑茶抽出物を含有する美白用化粧料組成物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP7613935B2 (ja)	2021-02-11	2025-01-15	月桂冠株式会社	フィラグリン増量剤

Also Published As

Publication number	Publication date
TW202102239A (zh)	2021-01-16
WO2020203933A1 (ja)	2020-10-08
CN113631227A (zh)	2021-11-09
TW202423464A (zh)	2024-06-16
TWI857919B (zh)	2024-10-01
JP2023171950A (ja)	2023-12-05
KR20210144725A (ko)	2021-11-30
CN113631227B (zh)	2024-05-17

Publication	Publication Date	Title
JP2021502953A (ja)	2021-02-04	ツボクサ不定根抽出物を有効成分として含有する皮膚美白及びシワ改善用化粧料組成物
TW201206494A (en)	2012-02-16	Use of Tiliacora triandra in cosmetics and compositions thereof
KR101303295B1 (ko)	2013-09-03	겨우살이 발효추출물, 모근 발효추출물 및 콩 발효추출물을 유효성분으로 포함하는 세포 증식 촉진 또는 손상된 피부 회복 촉진용 발효 화장료 조성물
KR20230147028A (ko)	2023-10-20	대마 줄기 추출물을 유효성분으로 포함하는 항노화, 항염 또는 피부재생용 조성물
JP2023171950A (ja)	2023-12-05	抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料
KR101532003B1 (ko)	2015-06-26	발효 조성물을 함유하는 피부 항산화 기능성 화장품
KR101336804B1 (ko)	2013-12-03	버섯을 이용한 전복 버섯 발효물, 이의 제조방법 및 이를 포함하는 화장품 조성물
KR20190063549A (ko)	2019-06-10	대나무 발효물을 함유하는 화장료 조성물
JP6437297B2 (ja)	2018-12-12	特定の波長域を有する光を照射して栽培したセージの抽出物を含有する皮膚外用剤や内用剤
KR102526287B1 (ko)	2023-04-27	쌍별귀뚜라미 추출물의 발효물을 유효성분으로 함유하는 항염증 및 주름 개선용 조성물
KR20130001842A (ko)	2013-01-07	쪽동백 추출물을 포함하는 피부 미백용 화장료 조성물 및 화장방법
KR102054100B1 (ko)	2020-01-22	뿌리식물 혼합 발효추출물을 함유하는 피부개선용 화장료 조성물
KR101587077B1 (ko)	2016-01-21	피부 생리활성을 가지는 백년초 발효물을 포함하는 조성물
FR2928549A1 (fr)	2009-09-18	Utilisation d'un extrait de l'orchidee brassocattleya marcella koss en tant qu'actif pour prevenir ou retarder l'apparition des signes du vieillissement cutane
KR102017132B1 (ko)	2019-09-03	실론시나몬나무껍질 및 구릿대의 혼합발효추출물을 함유하는 화장료 조성물
KR101957435B1 (ko)	2019-03-12	피부 주름 예방 또는 개선용 누에고치 발효물의 제조방법 및 이를 유효성분으로 함유하는 화장료 조성물
KR102453167B1 (ko)	2022-10-11	식물성 세라마이드 성분을 함유하는 피부개선용 화장료 조성물
KR101207560B1 (ko)	2012-12-03	빗죽이나무 추출물을 유효성분으로 함유하는 화장료 조성물
KR101207559B1 (ko)	2012-12-05	윤노리나무 추출물을 유효성분으로 함유하는 화장료 조성물
KR20170137559A (ko)	2017-12-13	복합 생약 추출물을 포함하는 피부 개선용 조성물
JP2015221791A (ja)	2015-12-10	特定の波長域を有する光を照射して栽培したクウシンサイの抽出物を含有する皮膚外用剤や内用剤。
KR101778538B1 (ko)	2017-09-15	인삼 열매 귀부균 발효물을 함유하는 화장료 조성물
KR102504878B1 (ko)	2023-03-02	능소화 꽃, 매화 꽃, 붉가시나무의 가지 또는 잎의 혼합발효추출물을 유효성분으로 하는 항염, 피부진정 및 가려움증 개선용 화장료 조성물
KR102182927B1 (ko)	2020-11-26	꽃송이버섯 균사체를 이용한 불미나리 발효추출물을 포함하는 피부 항산화, 주름 개선, 탄력 개선 또는 미백용 화장료 조성물 및 이의 제조방법
JP6744537B2 (ja)	2020-08-19	毛髪の成長を促進させる組成物

Legal Events

Date	Code	Title	Description
2022-03-09	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220309
2022-05-27	RD03	Notification of appointment of power of attorney	Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20220527
2022-12-06	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221206
2023-01-27	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230127
2023-04-03	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230403
2023-07-11	A02	Decision of refusal	Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20230711

JP2020164486A - 抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料 - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (7)

Applications Claiming Priority (1)

Related Child Applications (1)

Publications (1)

Family

ID=72669004

Family Applications (2)

Family Applications After (1)

Country Status (5)

Cited By (1)

Families Citing this family (2)

Citations (14)

Family Cites Families (35)

Patent Citations (14)

Cited By (1)

Also Published As

Similar Documents

Legal Events